Pulmonary and cardiovascular effects of mefloquine methanesulfonate.
D000403:Airway Resistance / Q000187:drug effects; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D002245:Carbon Dioxide / Q000097:blood; D003326:Coronary Circulation / Q000187:drug effects; D004285:Dogs; D004562:Electrocardiography; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006632:Histamine / Q000494:pharmacology; D008168:Lung / Q000187:drug effects*; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects; D010100:Oxygen / Q000097:blood; D010880:Piperidines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects; D013990:Tidal Volume
D000962:Antimalarials; D010880:Piperidines; D011804:Quinolines; D002245:Carbon Dioxide; D006632:Histamine; D010100:Oxygen